Embecta Executive and Leadership Team

Devdatt Kurdikar, the President & Chief Executive Officer & Chair of the Board at Embecta, directs the company's overarching strategy and governance. Overseeing all facets of the business, the President & Chief Executive Officer & Chair of the Board ensures alignment with Embecta's mission to provide critical diabetes treatment equipment. This leadership position involves driving innovation in medical device manufacturing and expanding market reach across key global territories. By setting the strategic vision, Devdatt Kurdikar guides the executive team in achieving operational excellence and financial growth. The President & Chief Executive Officer & Chair of the Board's focus remains on enhancing Embecta's position as a leader in diabetes care solutions, ensuring sustainable development and robust stakeholder value. Kurdikar's strategic direction underpins the company's commitment to improving patient lives through advanced medical technology.

Jacob Elguicze, the Senior Vice President, Chief Financial Officer at Embecta, manages the company's financial operations and strategic fiscal planning. Overseeing all aspects of financial reporting, budgeting, and investment, the Senior Vice President, Chief Financial Officer ensures Embecta's fiscal health and supports its growth objectives in the diabetes medical equipment market. This position involves driving financial performance, managing capital allocation, and mitigating financial risks across global operations. By providing critical financial insights, Jacob Elguicze guides executive decisions to optimize profitability and shareholder value. The Senior Vice President, Chief Financial Officer's leadership is essential for maintaining financial integrity and enabling Embecta's mission to deliver innovative diabetes treatment solutions. Elguicze's financial acumen strengthens Embecta's capacity for sustained development and market leadership.

Jenna Sharpe, the Chief Marketing Officer at Embecta, spearheads all global marketing initiatives and brand strategy. Overseeing market analysis and product positioning, the Chief Marketing Officer ensures Embecta's medical equipment effectively reaches healthcare providers and patients managing diabetes. This role involves developing comprehensive go-to-market plans and driving demand generation across diverse geographic regions. By understanding market dynamics, Jenna Sharpe guides the creation of compelling messaging that highlights the benefits of Embecta's specialized diabetes treatment solutions. The Chief Marketing Officer's efforts are crucial for expanding the company's footprint and reinforcing its reputation for quality and innovation in the medical device sector. Sharpe's leadership in marketing directly supports Embecta's objective to improve diabetes management worldwide through accessible and advanced technology.

Michael Lorusso, the Head Chief Information Officer, Shared Services at Embecta, directs the company's information technology infrastructure and shared service operations. Overseeing the implementation of robust digital solutions, the Head Chief Information Officer, Shared Services ensures seamless technological support for Embecta's global manufacturing and distribution of diabetes care equipment. This critical role involves managing IT security, optimizing data management systems, and driving digital transformation initiatives. By leveraging technology, Michael Lorusso enhances operational efficiency and supports the company's strategic objectives. The Head Chief Information Officer, Shared Services's focus is on building scalable and secure IT platforms that empower Embecta's workforce and facilitate innovation in medical device technology. Lorusso's expertise is vital for maintaining Embecta's competitive edge in the healthcare technology landscape.

Leisha Ayres, the Head Chief Information Officer, Shared Services at Embecta, oversees the strategic direction and execution of information technology services and shared operational functions. Managing the integration of advanced technological solutions, the Head Chief Information Officer, Shared Services ensures that Embecta's global infrastructure effectively supports the manufacturing and distribution of vital diabetes care equipment. This leadership role involves enhancing cybersecurity protocols, optimizing enterprise resource planning systems, and driving digital innovation across the organization. By focusing on technological advancement, Leisha Ayres contributes to operational efficiency and the company's ability to adapt to evolving market demands. The Head Chief Information Officer, Shared Services's commitment to robust IT frameworks is fundamental to Embecta's mission of improving patient outcomes through reliable medical devices. Ayres's expertise strengthens Embecta's technological foundation for future expansion.

Jean Casner, the Senior Vice President and Chief Human Resources Officer at Embecta, leads all human capital strategies and organizational development initiatives. Overseeing talent acquisition, employee engagement, and workforce planning, the Senior Vice President and Chief Human Resources Officer ensures Embecta cultivates a high-performing culture essential for manufacturing advanced diabetes treatment equipment. This position involves developing comprehensive HR policies, managing compensation and benefits, and fostering a diverse and inclusive work environment across global operations. By championing employee development, Jean Casner supports the company's mission to innovate and deliver critical medical solutions. The Senior Vice President and Chief Human Resources Officer's strategic focus on people is integral to Embecta's long-term success and its ability to attract and retain top talent in the competitive medical technology sector. Casner's leadership strengthens Embecta's human capital.

Henry Anhalt, the Global Chief Medical Officer, Head Medical, Clinical Scientific Affairs at Embecta, provides critical medical and scientific leadership for the company's diabetes care products. Overseeing clinical strategy and scientific affairs, the Global Chief Medical Officer, Head Medical, Clinical Scientific Affairs ensures Embecta's medical equipment meets the highest standards of patient safety and efficacy. This role involves guiding research and development, advising on clinical trial design, and fostering relationships with the medical community worldwide. By translating medical insights into product development, Henry Anhalt drives innovation that directly benefits individuals managing diabetes. The Global Chief Medical Officer, Head Medical, Clinical Scientific Affairs's expertise is vital for maintaining Embecta's commitment to advancing diabetes treatment technology and improving patient lives. Anhalt's medical guidance shapes Embecta's product pipeline and market credibility.